All In MedTech

Device Trial Radar · NCT07223164

Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

102

Actual

Start

Oct 21, 2025

Primary completion

Oct 31, 2025

Study completion Oct 31, 2025

Sponsor

Lead sponsor
Masimo CorporationPublic (MASI)
Sponsor type
Industry
First posted
Oct 31, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is designed to validate the performance of Masimo Irregular Heartbeat Detection algorithm using Masimo SET® in detecting atrial fibrillation. The measurements will be compared to results obtained from Masimo Radius VSM®.

Conditions

  • Healthy

Interventions

  • Masimo SET®Device

    Pulse oximeter device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Specificity Measures the % of True Negatives for Atrial Fibrillation Detection in Participants With Normal Sinus Rhythm.Time frame: 1-2 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Masimo Corporation

    Irvine, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.